Gombar C T, Magee P N
Chem Biol Interact. 1982 Jun;40(2):149-57. doi: 10.1016/0009-2797(82)90097-7.
The ability of the nitroso derivative of the drug cimetidine to interact with cellular macromolecules in the intact rat was investigated. Radio-labelled nitrosocimetidine (NC) was shown to methylate DNA in a variety of tissues in the rat after oral administration. Radioactivity was also detected in the RNA and protein extracted from these same tissues. Methylation of DNA by the parent compound, cimetidine, was not detected in any of the tissues studied. For comparison, the DNA methylation produced by the carcinogen N-methyl-N-nitro-N-nitrosoguanidine (MNNG) dosed orally was measured. DNA alkylation by MNNG was found to be approx. 2-36 times greater than that produced by NC, varying with the tissues studied. The highest yield of DNA alkylation was found in the stomach for MNNG and the small intestine for nitrosocimetidine suggesting pharmacokinetic differences.
研究了药物西咪替丁的亚硝基衍生物与完整大鼠体内细胞大分子相互作用的能力。口服放射性标记的亚硝基西咪替丁(NC)后,在大鼠的多种组织中显示其可使DNA甲基化。从这些相同组织中提取的RNA和蛋白质中也检测到了放射性。在所研究的任何组织中均未检测到母体化合物西咪替丁对DNA的甲基化作用。作为比较,测定了口服致癌物N-甲基-N-硝基-N-亚硝基胍(MNNG)产生的DNA甲基化。发现MNNG引起的DNA烷基化比NC产生的烷基化大约2至36倍,具体取决于所研究的组织。MNNG引起的DNA烷基化在胃中的产量最高,而亚硝基西咪替丁引起的DNA烷基化在小肠中的产量最高,这表明存在药代动力学差异。